Randomized Controlled Trial
Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.
Clin Ther. 2005 Oct 1;27(10):1548-61.
Randomized Controlled Trial
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes...
Clin Ther. 2011 Jul 1;33(7):973-89.
Randomized Controlled Trial
Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trial.
Clin Ther. 2012 Sep 1;34(9):1909-19.e15.